LISATA THERAPEUTICS, INC. Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax
LISATA THERAPEUTICS, INC. (LSTA) had Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax of $0 as of 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2018-05-10
- 2018-03-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $0.00.
- 2017-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $0.00.
- 2017-09-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $100.00.
- 2017-06-30: Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax $100.00.
| Period end | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2018-03-31 | $0.00 10-Q · filed 2018-05-10 |
| 2017-12-31 | $0.00 10-Q · filed 2018-05-10 |
| 2017-09-30 | $100.00 10-Q · filed 2017-11-09 |
| 2017-06-30 | $100.00 10-Q · filed 2017-08-10 |
| 2016-12-31 | $0.00 10-Q · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |